Haffkine Biopharmaceuticals
Mumbai, India· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
Overview
A government-owned Indian biopharmaceutical company producing essential vaccines, antitoxins, and pharmaceutical products for public health.
Infectious DiseaseToxicology
Technology Platform
Traditional biologics manufacturing platform for bacterial/viral vaccines and polyclonal antisera production using equine hyperimmunization and plasma fractionation.
Opportunities
Opportunities include leveraging its government mandate to modernize facilities and expand production of essential vaccines and antitoxins for India's growing public health needs, including potential for new vaccine introductions.
Risk Factors
Key risks include dependence on government procurement policies and budgets, potential technological lag compared to private sector innovators, and operational inefficiencies inherent in some state-owned enterprises.
Competitive Landscape
HBPCL competes with large Indian vaccine manufacturers like Serum Institute of India and Bharat Biotech, as well as multinationals, but is differentiated by its government ownership, focus on affordable public health products, and unique expertise in traditional antitoxin production.